Abstract
Background and Aim: Tissue injury leads to activation of coagulation and generation of thrombin. Inhibition of thrombin receptor protease‐activated receptor 1 (PAR‐1) has been shown to reduce liver fibrosis in animals. This study aimed to evaluate the effect ofPAR‐1gene polymorphism on rate of liver fibrosis (RF) in chronic hepatitis C.Methods: Polymorphisms studied: C > T transition 1426 bp upstream of translation start site (‐1426C/T), 13 bp repeat of preceding ‐506 5′‐CGGCCGCGGGAAG‐3′ sequence (‐506I/D), and A > T transversion in intervening sequence (IVS) 14 bp upstream of exon‐2 start site (IVS‐14A/T). A total of 287 European and 90 Brazilian patients were studied.Results: 1426C/T polymorphism: There was a trend to higher RF in patients with the TT genotype (P = 0.06) and an association between genotype CC and slow fibrosis (P = 0.03) in Europeans. In males, RF was significantly higher in those with the TT genotype compared to CT (P = 0.003) and CC (P = 0.007). There was a significant association between TT and fast fibrosis (P = 0.04). This was confirmed in an independent cohort of Brazilians where RF was higher in TT than in CC (P = 0.03). Analysis of ‐506I/D showed no difference in RF and distribution of slow/fast fibrosis among different genotypes in both populations. Analysis of IVS‐14A/T showed no difference between genotypes.Conclusion: In conclusion, these findings suggest that PAR‐1 receptor polymorphisms influence the progression of liver fibrosis.